From the Journals

COVID may increase risk of high blood pressure



Infection with COVID-19 may increase a person’s risk of developing high blood pressure, according to a new study.

High blood pressure already impacts about half of U.S. adults, and the study researchers expressed concern about the sheer number of people who have newly developed the condition.

Among people in the study who had COVID but didn’t have a history of high blood pressure:

  • One in five who had been hospitalized with COVID developed high blood pressure within 6 months.
  • One in 10 who had COVID but were not hospitalized developed high blood pressure within 6 months.

The study appeared in Hypertension, a journal published by the American Heart Association. The researchers analyzed data for more than 45,000 people who had COVID from March 2020 to August 2022. The people did not have a history of high blood pressure. All of them were treated at the Montefiore Health System in New York, and had returned to the hospital system for any medical reason within an average of 6 months.

In an analysis to evaluate the impact of COVID, the researchers compared the likelihood of new high blood pressure in people who had the flu to the people who had COVID. The hospitalized COVID patients were more than twice as likely to get high blood pressure, compared with hospitalized flu patients. People who had COVID but weren’t hospitalized were 1.5 times more likely to get high blood pressure, compared with nonhospitalized flu patients.

People at greatest risk were age 40 or older or men, or had conditions such as chronic obstructive pulmonary disease (COPD), coronary artery disease, and chronic kidney disease.

The authors noted that the people in the study mostly lived in a low socioeconomic area, which can be a risk factor for high blood pressure. Aspects of the pandemic other than the virus itself could have impacted high blood pressure risk, too, like isolation, low activity levels, poor diet, and psychological stress. The researchers said further study is needed to overcome limitations of their research, in particular that it only included people who interacted with the health care system, and that they didn’t know if some people already had high blood pressure that was just undiagnosed.

“Given the sheer number of people affected by COVID-19, compared to influenza, these statistics are alarming and suggest that many more patients will likely develop high blood pressure in the future, which may present a major public health burden,” researcher Tim Q. Duong, PhD, professor of radiology at Albert Einstein College of Medicine and Montefiore Health System, New York, said in a statement. “These findings should heighten awareness to screen at-risk patients for hypertension after COVID-19 illness to enable earlier identification and treatment for hypertension-related complications, such as cardiovascular and kidney disease.”

A version of this article appeared on

Recommended Reading

Cardiac issues twice as likely with COVID plus high troponin
MDedge Cardiology
COVID-19 shot appears to reduce diabetes risk, even after Omicron
MDedge Cardiology
What’s new in brain health?
MDedge Cardiology
‘Breakthrough’ study: Diabetes drug helps prevent long COVID
MDedge Cardiology
FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
MDedge Cardiology
Long COVID hitting some states, minorities, women harder
MDedge Cardiology
Clinical trials: Top priority for long COVID
MDedge Cardiology
Hyperbaric oxygen may improve heart function in long COVID
MDedge Cardiology
Review supports continued mask-wearing in health care visits
MDedge Cardiology
International rights group calls out United States for allowing hospitals to push millions into debt
MDedge Cardiology